leading to cancer development. Alternatively, susceptibility to viral oncolysis may 23 change during cancer progression. These hypotheses were tested using cells from a 24 transgenic mouse model of prostate cancer infected with vesicular stomatitis virus 25 (VSV). Primary cultures from murine cancers derived from prostate-specific Pten 26 deletion contained a mixture of cells that were susceptible and resistant to VSV. VSV is currently in a phase I clinical trial for localized treatment of hepatocellular 68 carcinoma (2). However, one of the major challenges to oncolytic virus therapy is that 69 individual cancer cell lines vary dramatically in their sensitivity to oncolytic viruses, even 70 when these cancers arise from the same tissue type (7, 13, (17) (18) (19) (20) (21) (22) . The experiments 71 presented here address the origin of these differences in susceptibility to oncolytic VSV 72 among prostate cancers. and/or radical prostatectomy typically achieve > 90% disease-free survival within five 78 years (24, 25). However, treatment for metastatic disease is less effective (26 The recombinant viruses, rwt and rM51R, as well as viruses encoding GFP and a 164 palmitoylated form of dsRed were prepared in BHK cells as described (38) . (Fig. 6) . 353
Most control Pten
L/L and acutely deleted Pten -/-cells were killed by either virus by 36-48 354 hours postinfection (Fig. 6A, B (Fig. 6C ) and about 75% remaining viable after infection with rM51R virus 360 (Fig. 6D) . Some of the resistant cells continue to divide following infection with VSV 361 The difference in responses of tumor-derived Pten -/-cells was even more striking 365 in multiple cycle infections (MOI of 0.1, Fig. 7) . Pten L/L or acutely deleted Pten -/-cells 366 were largely nonviable by 48 hours postinfection with either rwt or rM51R virus (Fig. 7A,  367 B), indicating that virus had spread throughout the culture from the initially infected cells. control Pten L/L , acutely deleted, and tumor-derived Pten -/-cells were analyzed for 378 STAT1 expression and activation by phosphorylation by immunoblots. Cells were mock-379 infected or infected with rwt or rM51R virus at MOI of 10, and cell lysates were prepared 380 at 6 and 12 hours postinfection. Lysates were analyzed by immunoblots using 381 antibodies against phospho-or total STAT1 (Fig. 8) . Mock-infected tumor-derived Pten deleted Pten -/-cells (Fig. 8A, C) . Furthermore, STAT1 was phosphorylated in response 384 to infection of tumor-derived cells with rwt virus (Fig. 8A, B (Fig. 8A, B) , due to the 387 inhibitory activity of the wt M protein, which prevents IFN production in most cell types. 388
All three cell types responded to infection with M protein mutant virus by 389 phosphorylation of STAT1 (Fig. 8D, E (Fig. 2, 3) . Likewise, in 432 murine clonal cell populations, normal MPE progenitor cells were sensitive to VSV 433 infection (Figs. 4 -7) . VSV replication in normal murine prostates has been observed 434 following intraprostatic inoculation in vivo (47, 48). However, the virus was quickly 435 cleared in vivo, and there did not appear to be damage to the normal prostatic 436 epithelium. This is likely due to the responsiveness of the normal epithelial cells to type 437 I interferons (Fig. 9, 10a ) and other antiviral cytokines produced by immune cells. high levels of the antiviral transcription factor STAT1, which was activated upon virus 471 infection, even with wt VSV, which normally suppresses interferon synthesis in most cell 472 types (Fig. 8) . (Figs. 3, 10d) . This is important because men with 496 castration-resistant disease would be the target population for oncolytic virus therapy. 497
At least two possibilities that are not mutually exclusive could contribute to this effect. 498
One possibility is that cells that are IFN-responsive and resistant to VSV-infection are 499 more sensitive to effects of androgen withdrawal. As a result, the cells that remain and 500 
